Berkshire Hathaway finally started spending its nearly $400 billion in cash — on one stock it knows very well
THE SO WHAT
Berkshire using a nearly $400B cash pile to buy back its own stock is a reminder that even the most patient capital is struggling to find asymmetric opportunities at current prices. If you’re fundraising or selling secondary, assume more scrutiny on durable cash flows and less appetite for pure growth stories.
READ THE SOURCE
MORE FROM THE WIRE
These 40-something founders say they have something the AI kids don't
If experienced operators are leaning into the "age of the unc" narrative, the edge isn’t age—it’s distribution, domain knowledge, and scar tissue. For hiring and cofounder choices, overweight people who’ve shipped through multiple cycles over raw model tinkering skill.
Startups & VentureUK air defence startup Cambridge Aerospace hits $3.4bn valuation in new fundraise
A UK air defence startup reaching a $3.4B valuation per [Sifted](https://sifted.eu/articles/cambridge-aerospace-fundraise-valuation/) shows how fast dual-use and defence tech are repricing. If you’re building anything with sensing, autonomy, or secure comms, expect more defence-adjacent capital—and more export control complexity.
Startups & Venture‘I’m not here to be acquired’: Meet Nabla’s new CEO Brian Manning
A healthcare AI startup explicitly signaling “no quick acquisition” is a bet on owning workflow depth — not just building a feature for incumbents. If you’re selling into clinicians or payers, assume Nabla and peers will try to become primary systems of engagement, which raises the bar on integration, data rights, and long‑term independence in your own pitches.
Startups & VentureNYSE President on Asia Business, IPO Pipeline
NYSE leaning into Asia and talking up the IPO pipeline suggests cross-border listings will stay competitive despite regional tensions. If you’re a late-stage founder, keep dual-track options open—US listing venues are actively courting Asian and European issuers again.